PP
SPPI

PDT Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

PDT Partners’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-173,500
Closed -$592K – 920
2020
Q4 		$592K Buy
173,500
+23,694
+16% +$97.5K 0.04% 424
2020
Q3 		$611K Buy
149,806
+112,206
+298% +$427K 0.04% 396
2020
Q2 		$127K Sell
37,600
-88,800
-70% -$259K 0.01% 622
2020
Q1 		$295K Sell
126,400
-15,500
-11% -$42.4K 0.02% 480
2019
Q4 		$517K Buy
141,900
+27,541
+24% +$223K 0.03% 409
2019
Q3 		$949K Buy
+114,359
New +$925K 0.06% 289
2017
Q4 		– Sell
-142,000
Closed -$2M – 576
2017
Q3 		$2M Hold
142,000
– – 0.07% 277
2017
Q2 		$1.06M Buy
142,000
+18,800
+15% +$123K 0.04% 329
2017
Q1 		$801K Sell
123,200
-600
-0.5% -$3.35K 0.04% 339
2016
Q4 		$548K Buy
123,800
+4,300
+4% +$18K 0.04% 388
2016
Q3 		$558K Buy
119,500
+91,900
+333% +$544K 0.03% 360
2016
Q2 		$181K Buy
+27,600
New +$195K 0.01% 405
2015
Q4 		– Sell
-187,594
Closed -$1.12M – 1038
2015
Q3 		$1.12M Buy
187,594
+153,331
+448% +$1.06M 0.03% 682
2015
Q2 		$234K Sell
34,263
-45,658
-57% -$290K 0.01% 1203
2015
Q1 		$485K Sell
79,921
-104,100
-57% -$693K 0.01% 1025
2014
Q4 		$1.27M Sell
184,021
-52,100
-22% -$383K 0.12% 182
2014
Q3 		$1.92M Buy
236,121
+60,200
+34% +$471K 0.05% 429
2014
Q2 		$1.43M Hold
175,921
– – 0.04% 569
2014
Q1 		$1.38M Hold
175,921
– – 0.03% 587
2013
Q4 		$1.56M Sell
175,921
-78,700
-31% -$703K 0.19% 147
2013
Q3 		$2.14M Sell
254,621
-26,457
-9% -$214K 0.06% 463
2013
Q2 		$2.1M Buy
+281,078
New +$2.16M 0.05% 534

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

PDT Partners's SPPI Position: Q1 2021 in Review

PDT Partners sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2021, closing a stake of 173,500 shares — an estimated $592K sold.

PDT Partners first reported a position in SPPI in Q2 2013 and held it in 22 quarters. The position peaked at $2.14M in Q3 2013. 147 funds tracked by Wall St. Rank hold SPPI as of Q1 2021.

  • PDT Partners reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
  • PDT Partners sold 173,500 Spectrum Pharmaceuticals Inc shares in Q1 2021, an estimated $592K.
  • PDT Partners first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
  • PDT Partners's Spectrum Pharmaceuticals Inc position peaked at $2.14M in Q3 2013.
  • 147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2021.

Based on PDT Partners's 13F filing for Q1 2021, filed 17 May 2021.